Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells

Xenobiotica

Volumn 29, Issue 12, 1999, Pages 1241-1256

  Galijatovic, A ^a   Otake, Y ^a   Walle, U K ^a   Walle, T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; APIGENIN; ARYL SULFOTRANSFERASE; CHRYSIN; GLUCURONIC ACID;

ARTICLE; CELL CULTURE; CELL METABOLISM; CELL STRAIN CACO 2; CELL STRAIN HEPG2; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

EID: 0033391399     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599237912     Document Type: Article

References (55)

1. Abe, K. I., Inoue, O. and Yumioka, E., 1990, Biliary excretion of metabolites of baicalin and baicalein in rats. Chemical and Pharmaceutical Bulletin, 38, 208-211.
2. Abid, A., Bouchon, I., Siest, G. and Sabolovic, N., 1995, Glucuronidation in the Caco-2 human intestinal cell line: Induction of UDP-glucuronosyltransferase 1 *6. Biochemical Pharmacology, 50, 557-561.
3. Baranczyk-Kuzma, A., Garren, J. A., Hidalgo, I. J. and Borchardt, R. T., 1991, Substrate specificity and some properties of phenol sulfotransferase from human intestinal Caco-2 cells. Life Sciences, 49, 1197-1206.
4. Bjorge, S., Hamelehle, K. L., Homan, R., Rose, S. E., Turluck, D. A. and Wright, D. S., 1991, Evidence for glucuronide conjugation of p-nitrophenol in the Caco-2 cell model. Pharmaceutical Research, 8, 1441-1443.
5. Boulton, D. W., Walle, U. K. and Walle, T., 1999, Fate of the flavonoid quercetin in human cell lines: Chemical instability and metabolism. Journal of Pharmacy and Pharmacology 51, 353-359.
6. Boutin, J. A., Meunier, F., Lambert, P. H., Hennig, P., Bertin, D., Serkiz, B. and Volland, J. P., 1993, In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats. Drug Metabolism and Disposition, 21, 1157-1166.
7. Campbell, N. R. C., Van Loon, J. A. and Weinshilboum, R. M., 1987, Human liver phenol sulfotransferase: Assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochemical Pharmacology, 36, 1435-1446.
8. Chikhale, P. J. and Borchardt, R. T., 1994, Metabolism of L-α-methyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers - Comparison with metabolism in vivo. Drug Metabolism and Disposition, 22, 592-600.
9. Ciolino, H. P., Daschner, P. J., Wang, T. T. Y. and Yeh, G. C., 1998, Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochemical Pharmacology, 56, 197-206.
10. Comer, K. A. and Falany, C. N., 1992, Immunological characterization of dehydroepiandrosterone sulfotransferase from human liver and adrenal. Molecular Pharmacology, 41, 645-651.
11. Critchfield, J. W., Butera, S. T. and Folks, T. M., 1996, Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Research and Human Retroviruses, 12, 39-46.
12. Critchfield, J. W., Coligan, J. E., Folks, T. M. and Butera, S. T., 1997, Casein kinase II is a selective target of HIV-1 transcriptional inhibitors. Proceedings of the National Academy of Sciences, USA, 94, 6110-6115.
13. Falany, C. N., Wheeler, J., Oh, T. S. and Falany, J. L., 1994, Steroid sulfation by expressed human cytosolic sulphotransferases. Journal of Steroid Biochemistry and Molecular Biology, 48, 369-375.
14. Ganguly, T. C., Krasnykh, V. and Falany, C. N., 1995, Bacterial expression and kinetic characterization of the human monoamine-sulfating form of phenol sulfotransferase. Drug Metabolism and Disposition, 23, 945-950.
15. Green, M. D., King, C. D., Mojarrabi, B., Mackenzie, P. I. and Tephly, T. R., 1998, Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metabolism and Disposition, 26, 507-512.
16. Green, M. D., Oturu, E. M. and Tephly, T. R., 1994, Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metabolism and Disposition, 22, 799-805.
17. 2-receptor agonists by the human intestine and the recombinant M-form phenolsulfotransferase. Chirality, 10, 800-803.
18. Hertog, M. G. L., Hollman, P. C. H. and Katan, M. B., 1992, Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. Journal of Agricultural and Food Chemistry, 40, 2379-2383.
19. Hertog, M. G. L., Hollman, P. C. H. and Van De Putte, B., 1993, Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. Journal of Agricultural and Food Chemistry, 41, 1242-1246.
20. Jäger, W., Zembsch, B., Wolschann, P., Pittenauer, E., Senderowicz, A. M., Sausville, E. A., Sedlacek, H. H., Graf, J. and Thalhammer, T., 1998, Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver. Life Sciences, 62, 1861-1873.
21. Keli, S. O., Hertog, M. G. L., Feskens, E. J. M. and Kromhout, D., 1996, Dietary flavonoids, antioxidant vitamins, and incidence of stroke: The Zutphen study. Archives of Internal Medicine, 156, 637-642.
22. Knekt, P., Järvinen, R., Reunanen, A. and Maatela, J., 1996, Flavonoid intake and coronary mortality in Finland: A cohort study. British Medical Journal, 312, 478-481.
23. Kühnau, J., 1976, The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Review of Nutrition and Dietetics, 24, 117-191.
24. 1 cell-cycle arrest by the chemopreventive agent apigenin. Molecular Carcinogenesis, 19, 74-82.
25. Lewis, A. J., Kelly, M. M., Walle, U. K., Eaton, E. A., Falany, C. N. and Walle, T., 1996, Improved bacterial expression of the human P form phenolsulfotransferase - Applications to drug metabolism. Drug Metabolism and Disposition, 24, 1180-1185.
26. Li, W., Harper, P. A., Tang, B. K. and Okey A. B., 1998, Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells - CYP1A2 expression in the LS180 colon carcinoma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene. Biochemical Pharmacology, 56, 599-612.
27. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
28. Mabry, T. J., Markham, K. R. and Thomas, M. B., 1970, chapter V-3. The UV spectra of flavones and flavonols in the presence of NaOAc. In The Systematic Identification of Flavonoids (New York: Springer), pp. 48-49.
29. Manach, C., Morand, C., Crespy, V., Demigné, C., Texier, O., Régérat, F. and Rémésy, C., 1998, Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Letters, 426, 331-336.
30. McMillan, J. M. and Jollow, D. J., 1992, Galactosamine hepatotoxicity: Effect of galactosamine on glutathione resynthesis in rat primary hepatocyte cultures. Toxicology and Applied Pharmacology, 115, 234-240.
31. Meunier, V., Bourrié, M., Berger, Y. and Fabre, G., 1995, The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biology and Toxicology, 11, 187-194.
32. Moon, J. Y., Lee, D. W. and Park, K. H., 1998, Inhibition of 7-ethoxycoumarin O-deethylase activity in rat liver microsomes by naturally occurring flavonoids: Structure-activity relationships. Xenobiotica, 28, 117-126.
33. Münzel, P. A., Bookjans, G., Mehner, G., Lehmköster, T. and Bock, K. W., 1996, Tissue-specific 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of human UDP-glucuronosyltransferase UGT1A6. Archives of Biochemistry and Biophysics, 335, 205-210.
34. Münzel, P. A., Lehmköster, T., Brück, M., Ritter, J. K. and Bock, K. W., 1998, Aryl hydrocarbon receptor-inducible or constitutive expression of human UDP glucuronosyltransferase UGT1A6. Archives of Biochemistry and Biophysics, 350, 72-78.
35. Nielsen, S. E., Breinholt, V., Justesen, U., Cornett, C. and Dragsted, L. O., 1998, In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica, 28, 389-401.
36. Oldham, J. W., Casciano, D. A. and Cave, M. D., 1980, Comparative induction of unscheduled DNA synthesis by physical and chemical agents in non-proliferating primary cultures of rat hepatocytes. Chemico-biological Interactions, 29, 303-314.
37. Peters, W. H. M., Kock, L., Nagengast, F. M. and Kremers, P. G., 1991, Biotransformation enzymes in human intestine: Critical low levels in the colon? Gut, 32, 408-412.
38. Prueksaritanont, T., Gorham, L. M., Hochman, J. H., Tran, L. O. and Vyas, K. P., 1996, Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. Drug Metabolism and Disposition, 24, 634-642.
39. Sergent-Engelen, T., Delistrie, V. and Schneider, Y. J., 1993, Phase I and II biotransformations in living Caco-2 cells cultivated under serum-free conditions - Selective apical excretion of reaction products. Biochemical Pharmacology, 46, 1393-1401.
40. Shimamura, H., Suzuki, H., Hanano, M., Suzuki, A. and Sugiyama, Y., 1993, Identification of tissues responsible for the conjugative metabolism of liquiritigenin in rats: An analysis based on metabolite kinetics. Biological and Pharmaceutical Bulletin, 16, 899-907.
41. Siess, M. H., Le Bon, A. M., Canivenc-Lavier, M. C., Amiot, M. J., Sabatier, S., Aubert, S. Y. and Suschetet, M., 1996, Flavonoids of honey and propolis: Characterization and effects on hepatic drug-metabolizing enzymes and benzo[a]pyrene-DNA binding in rats. Journal of Agricultural and Food Chemistry 44, 2297-2301.
42. Steiner, A., Walle, U. K. and Walle, T., 1992, Induction of propranolol metabolism in the Hep G2 human hepatoma cell line. Journal of Pharmacy and Pharmacology, 44, 611-614.
43. Strassburg, C. P., Manns, M. P. and Tukeys, R. H., 1998, Expression of the UDP-glucuronosyltransferase 1A locus in human colon - Identification and characterization of the novel extrahepatic UGT1A8. Journal of Biological Chemistry, 273, 8719-8726.
44. Strassburg, C. P., Nguyen, N., Manns, M. P. and Tukey, R. H. 1999, UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology, 116, 149-160.
45. Sundaram, R. S., Szumlanski, C., Otterness, D., Van Loon, J. A. and Weinshilboum, R. M., 1989, Human intestinal phenol sulfotransferase: Assay conditions, activity levels and partial purification of the thermolabile form. Drug Metabolism and Disposition, 17, 255-264.
46. Tsyrlov, I. B., Mikhailenko, V. M. and Gelboin, H. V., 1994, Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. Biochimica et Biophysica Acta, 1205, 325-335.
47. Varin, L., Barron, D. and Ibrahim, R. K., 1987, Enzymatic assay for flavonoid sulfotransferase. Analytical Biochemistry, 161, 176-180.
48. Walgren, R. A., Walle, U. K. and Walle, T., 1998, Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochemical Pharmacology, 55, 1721-1727.
49. Walle, T., Eaton, E. A. and Walle, U. K., 1995, Quercetin, a potent and specific inhibitor of the human P-form phenolsulfotransferase. Biochemical Pharmacology, 50, 731-734.
50. Walle, T., Walle, U. K., Shwed, J. A., Thornburg, K. R., Mathis, C. E. and Pesola, G. R., 1994, Human phenolsulfotransferases: Chiral substrates and expression in Hep G2 cells. Chemico- Biological Interactions, 92, 47-55.
51. Walle, T., Walle, U. K., Thornburg, K. R. and Schey, K. L., 1993, Stereoselective sulfation of albuterol in humans - Biosynthesis of the sulfate conjugate by Hep G2 cells. Drug Metabolism and Disposition, 21, 76-80.
52. Walle, U. K., Galijatovic, A. and Walle, T., 1999, Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochemical Pharmacology, 58, 431-438.
53. Weber, G., Shen, F., Prajda, N., Yeh, Y. A., Yang, H., Herenyiova, M. and Look, K. Y. 1996, Increased signal transduction activity and down-regulation in human cancer cells. Anticancer Research, 16, 3271-3282.
54. Wu, D., Ramin, S. A. and Cederbaum, A. I., 1997, Effect of pyridine on the expression of cytochrome P450 isozymes in primary rat hepatocyte culture. Molecular and Cellular Biochemistry, 173, 103-111.
55. Zhu, B. T., Ezell, E. L. and Liehr, J. G., 1994, Catechol-O-methyltransferase-catalyzed rapid O- methylation of mutagenic flavonoids: Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo. Journal of Biological Chemistry, 269, 292-299.